India’s E-Plan To Map Drug Sales – Turning Point For Better Traceability?
Executive Summary
A government plan aimed at putting in place an e-platform to regulate the sale of medicines in India, is expected to bolster end-to-end traceability and help lower the risk of fake drugs in the supply chain. But the platform’s proposed revenue model appears to be a sticking point, at least for now, among other tricky areas.
You may also be interested in...
India’s E-Pharmacy Rules – Balanced And A Leap Of Faith On Patient Data Security?
India’s draft e-pharmacy rules put in place a series of checks and balances to ensure that only genuine e-pharmacies engage in online sales of medicines. Registration and strict record keeping requirements, among other aspects, are mandated under the rules, though it may take a “leap of faith” when it comes to security of patient data, some experts say.
India Reschedules Drug Export Track And Trace Plan
India has deferred the implementation of its track and trace system for pharmaceutical exports - measures that are essentially aimed at curbing the menace of fake products and also enhance supply-chain safety1.
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.